Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
2.875
+0.005 (0.17%)
Apr 25, 2025, 11:28 AM EDT - Market open
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $245.88 million as of April 25, 2025. Its market cap has decreased by -23.32% in one year.
Market Cap
245.88M
Enterprise Value
-212.75M
1-Year Change
-23.32%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $245.88M, a decrease of -87.31%. That is a compound annual growth rate of -36.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 245.46M | -13.25% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.86B |
| UnitedHealth Group | 394.65B |
| Johnson & Johnson | 372.91B |
| AbbVie | 310.24B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.40B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |